A method for preparing irbesartan and intermediates thereof

Details for Australian Patent Application No. 2005277162 (hide)

Owner Bristol-Myers Squibb Company

Inventors Zhu, Jingyang; Miranda, Edgar I.; Vlaar, Cornelis

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005277162

PCT Pub. Number WO2006/023889

Priority 60/603,606 23.08.04 US

Filing date 23 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 16 December 2010

International Classifications

C07D 235/02 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/023889 Priority application(s): WO2006/023889

16 December 2010 Application Accepted

  Published as AU-B-2005277162

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005277172-Ingredient systems comprising trehalose, food products containing trehalose, and methods of making same

2005277156-T type calcium channel inhibitors